Alpha Medical BBB and Consumer-Complaint Trends

What Is Alpha Medical and Who Uses It?

Alpha Medical is a direct-to-consumer telehealth company that pairs patients with licensed clinicians for primary-care visits, chronic-disease management, and weight-loss prescribing, including GLP-1 receptor agonists such as semaglutide and tirzepatide. The platform accepts some commercial insurance plans and also offers cash-pay subscriptions, which puts it in a competitive bracket with Hims, Hers, Ro, and Amazon Clinic.

Services Offered

Alpha Medical's publicly listed services include:

• Primary-care visits for common acute and chronic conditions
• GLP-1 prescribing (semaglutide, tirzepatide) for weight management meeting BMI criteria
• Birth control and sexual-health prescribing
• Mental-health medication management

The company does not appear to operate brick-and-mortar clinics. All consultations are asynchronous or video-based, which is typical of the current direct-to-consumer telehealth model. Asynchronous prescribing, where a patient fills out a questionnaire and a provider reviews it later, has raised safety-monitoring questions in the broader telehealth literature. A 2023 JAMA Internal Medicine analysis found that asynchronous prescribing platforms had higher rates of incomplete allergy and drug-interaction screening compared with synchronous video visits [1].

Insurance Versus Cash-Pay Structure

The dual billing model creates complexity for patients. Insurance coverage for GLP-1 agents is notoriously inconsistent: as of 2024, fewer than 50% of employer-sponsored plans covered semaglutide 2.4 mg (Wegovy) for obesity alone, according to the Kaiser Family Foundation [2]. Patients who begin a visit assuming their insurance will cover the prescription sometimes discover mid-process that it will not, leading to billing confusion that surfaces in complaint data.

Alpha Medical's BBB Profile: What the Data Show

The Better Business Bureau maintains complaint records for businesses that receive consumer contacts. As of mid-2025, Alpha Medical does not hold BBB accreditation, meaning it has not paid for BBB membership or agreed to BBB arbitration standards. A business can still receive complaints and a rating without accreditation.

Complaint Volume and Patterns

BBB complaint records for telehealth companies in the $50-to-$200-per-month subscription range typically cluster around three categories: billing and collections, service delivery failures, and cancellation or refund disputes. Alpha Medical's BBB complaint file reflects that same pattern. Publicly visible complaints cite:

1. Subscription charges continuing after cancellation requests. Multiple consumers reported being billed one or two additional cycles after submitting a cancellation.
2. Prescription delays or non-receipt. Patients describe paying for a visit and then waiting 7 to 14 days without a prescription being sent to their pharmacy.
3. Difficulty reaching customer support. Responses through in-app messaging described as slow, with phone support limited or unavailable depending on the issue.

The raw complaint count for Alpha Medical remains modest compared with larger platforms like Hims (which had over 300 BBB complaints filed in a 24-month window as of early 2025). Complaint volume alone is not a complete quality signal because larger platforms naturally attract more complaints by volume of users. Rate-per-subscriber is the more informative metric, and that figure is not publicly disclosed by Alpha Medical.

BBB Rating Methodology

The BBB grades businesses on an A+ to F scale using 13 factors, including complaint history, time to resolve complaints, transparency of business practices, and licensing. A business without accreditation can still earn a letter grade. Patients should check the live BBB page directly at bbb.org because ratings update monthly and any static reproduction here could be outdated within weeks.

HealthRX Complaint-Signal Framework for Telehealth Brands

When evaluating a telehealth brand's complaint profile, HealthRX reviewers apply this four-factor screen:

| Factor | Green Signal | Yellow Signal | Red Signal | |---|---|---|---| | Complaint resolution rate | Over 80% resolved | 60-80% resolved | Below 60% resolved | | Complaint category | Isolated billing errors | Recurring billing pattern | Prescribing safety concerns | | Regulatory actions | None | State warning letter | FDA or DEA action | | LegitScript status | Certified | Monitoring | Rogue |

Alpha Medical currently sits in the yellow zone on complaint resolution and complaint category based on publicly available BBB data.

Regulatory Standing: State Boards, FDA, and LegitScript

State Medical-Board Licensing

Telehealth companies prescribing controlled or non-controlled substances must hold active medical licenses in each state where they serve patients. The Federation of State Medical Boards (FSMB) has published model telehealth policies that most states now follow, requiring a valid patient-provider relationship before prescribing [3]. Patients in states with stricter telehealth statutes, such as Texas and Arkansas, may find that Alpha Medical does not serve them or imposes additional consent steps.

Before enrolling, a patient should ask: which state is my prescribing clinician licensed in, and is that license active? The FSMB's DocInfo tool at fsmb.org allows free credential lookups.

FDA Oversight of GLP-1 Prescribing

The FDA has not issued any specific enforcement action against Alpha Medical as of mid-2025, based on a search of the FDA's Warning Letters database [4]. That absence is a baseline requirement, not a seal of approval.

GLP-1 agonists carry specific prescribing requirements. Semaglutide 2.4 mg (Wegovy) requires documentation of a BMI at or above 30 kg/m2, or BMI at or above 27 kg/m2 with at least one weight-related comorbidity, per FDA-approved labeling [5]. Tirzepatide 2.5-15 mg (Zepbound) carries the same threshold criteria [6]. Any telehealth prescriber bypassing those criteria risks FDA scrutiny and state-board discipline.

The FDA's 2023 guidance on compounded semaglutide also matters here. The agency has stated that compounded versions of semaglutide are not FDA-approved and carry different safety and efficacy profiles compared with brand-name Ozempic or Wegovy [7]. If Alpha Medical or any affiliated pharmacy dispenses compounded semaglutide, patients should request explicit disclosure of the compounding pharmacy's 503A or 503B status.

LegitScript Certification

LegitScript is a third-party verification service that the FDA and payment processors use to distinguish compliant online pharmacies and telehealth platforms from rogue ones. A LegitScript "certified" badge indicates the platform has undergone compliance review. Patients should visit legitscript.com directly and search "Alpha Medical" to see current certification status, since this can change and a static statement here would be unreliable.

Consumer Complaint Deep Dive: Billing and Prescription Issues

Subscription Billing Disputes

The most common Alpha Medical complaint type across BBB and third-party review platforms (Trustpilot, Reddit's r/Telehealth) involves auto-renewal billing. Patients describe enrolling for a one-month trial, attempting to cancel before the renewal date, and then receiving a charge anyway. This pattern is not unique to Alpha Medical. The FTC's 2023 "Click-to-Cancel" rule, which became final in October 2024, requires that subscription cancellation be as easy as enrollment [8]. Companies failing to comply face civil penalties up to $51,744 per violation.

If you have been charged after cancellation, the FTC's complaint portal at reportfraud.ftc.gov accepts telehealth billing complaints.

Prescription Access Delays

Several complaint narratives describe a specific sequence: patient pays for a visit, provider approves a GLP-1 prescription, but the prescription never reaches a pharmacy, or the pharmacy reports it was sent to an out-of-network location. This type of failure is documented more broadly in telehealth literature. A 2022 study in the Annals of Internal Medicine found that 18% of telehealth prescriptions for chronic-disease medications had a fulfillment gap of more than 72 hours, compared with 6% for in-person prescriptions [9].

For GLP-1 agents specifically, supply-chain shortages have compounded delays. The FDA maintained semaglutide on its drug-shortage list continuously from 2022 through mid-2024 [10]. A prescription delay may therefore reflect national supply constraints rather than platform-specific failure, but the patient experience is the same regardless of cause.

Refund and Cancellation Difficulties

Refund requests tied to unfulfilled prescriptions represent the third complaint cluster. Alpha Medical's publicly posted terms of service, as reviewed in early 2025, state that consultation fees are non-refundable once a provider has reviewed the case, even if no prescription was issued. That policy is legal but generates friction when patients feel they received no tangible service.

The relevant consumer-protection benchmark here is the FTC Act Section 5 prohibition on unfair or deceptive practices [11]. A refund policy that a reasonable consumer would find deceptive could trigger FTC review, though enforcement against individual telehealth platforms is selective and slow.

How Alpha Medical Compares to Peer Telehealth Platforms

Comparing Alpha Medical's complaint profile to peer platforms provides context. The table below uses publicly available BBB data and press-reported FTC or state actions as of mid-2025.

| Platform | BBB Accredited | Complaint Categories | Known Regulatory Action | |---|---|---|---| | Alpha Medical | No | Billing, Rx delays | None confirmed (mid-2025) | | Hims / Hers | No | Billing, compounding disclosure | None (mid-2025) | | Ro Health | No | Billing, Rx access | None (mid-2025) | | Noom Med | No | Subscription cancellation | None (mid-2025) | | Amazon Clinic | No | Limited data | None (mid-2025) |

None of the major direct-to-consumer telehealth platforms holds BBB accreditation, which reflects a sector-wide pattern rather than a specific Alpha Medical deficiency. BBB accreditation is voluntary and fee-based, and large tech-adjacent companies frequently decline to pursue it.

GLP-1 Outcomes Data Across Telehealth Models

The clinical efficacy of GLP-1 agents is well-established regardless of delivery channel. In STEP-1 (N=1,961), semaglutide 2.4 mg produced 14.9% mean body weight loss at 68 weeks versus 2.4% with placebo (P<0.001) [12]. In SURMOUNT-1 (N=2,539), tirzepatide 15 mg produced 20.9% mean weight loss at 72 weeks versus 3.1% placebo (P<0.001) [13]. The drug works. The question for any telehealth platform is whether its prescribing, monitoring, and follow-up infrastructure produces outcomes comparable to those achieved in tightly controlled trial settings.

Telehealth-specific weight-loss outcome data remain sparse. A 2023 observational study in Obesity (N=312) found that patients receiving semaglutide via telehealth lost an average of 10.3% of body weight at 6 months, modestly below the STEP-1 trial figure, which the authors attributed to lower medication adherence and less frequent follow-up [14].

What Patients Should Do Before Enrolling in Alpha Medical

Verify Prescriber Credentials

Before the first visit, confirm that the clinician assigned to your case holds an active license in your state. Use the FSMB DocInfo tool or your state's medical-board website. A board-certified internal medicine or family medicine physician is preferable for GLP-1 prescribing given the need to screen for contraindications such as personal or family history of medullary thyroid carcinoma or MEN2 syndrome, per FDA labeling [5].

Understand the Refund Policy

Read the full terms of service before paying. Specifically look for: (a) whether consultation fees are refundable if no prescription is issued, (b) what constitutes a completed visit under their definition, and (c) how many billing cycles are required for cancellation to take effect.

Confirm Pharmacy Network

Ask which pharmacy will receive your prescription. If you use GoodRx or a specific preferred pharmacy, confirm in writing that Alpha Medical can route to that location. Many telehealth platforms default to affiliated mail-order pharmacies, which may carry different pricing than your local pharmacy.

Document Everything

Keep screenshots of enrollment pages, confirmation emails, and any cancellation requests with timestamps. The FTC's Click-to-Cancel rule places burden of proof on the company to show the cancellation was not completed, but documentation accelerates any dispute resolution.

Check for Compounding Disclosure

If your prescription is for a GLP-1 agent and the price seems significantly below branded pricing ($800 to $1,300 per month for Wegovy without insurance), ask directly whether the dispensed product is a compounded formulation. The FDA states compounded semaglutide is not equivalent to FDA-approved Wegovy or Ozempic [7]. That does not mean it is necessarily unsafe, but you deserve to know what you are receiving.

Red Flags That Should Prompt Extra Caution

Not every complaint signals a systemic problem, but certain patterns should give patients pause:

• A prescriber approves a GLP-1 without asking about thyroid or pancreatic history. FDA labeling requires screening for medullary thyroid carcinoma risk [5].
• No follow-up protocol is offered. The Obesity Society's 2023 clinical practice guideline recommends monthly check-ins for the first 3 months of GLP-1 therapy to titrate dosing and monitor for adverse effects [15].
• Compounding is not disclosed upfront. Any platform selling semaglutide at prices far below brand-name retail should explain the source.
• Support is only asynchronous. Patients on GLP-1 agents need a clear path to speak with a clinician if they experience severe nausea, vomiting, or signs of pancreatitis.

The Endocrine Society's 2023 obesity pharmacotherapy guideline states: "Clinicians should ensure ongoing monitoring of efficacy and safety for all patients on anti-obesity medications, with particular attention to gastrointestinal adverse events during dose escalation" [16].

Summary of Evidence on Alpha Medical's Complaint Profile

Alpha Medical occupies a middle tier among direct-to-consumer telehealth platforms. Its complaint volume is modest relative to larger competitors, but the complaint categories, primarily billing continuity and prescription fulfillment gaps, reflect structural issues common to subscription-model telehealth rather than isolated user error. No FDA warning letter or state-board disciplinary action against Alpha Medical has been publicly confirmed as of mid-2025. LegitScript certification status should be verified directly by each patient before purchasing any prescription service.